دورية أكاديمية
MO01.19 An Indirect Comparison of Pembrolizumab Monotherapy Versus Ipilimumab+Nivolumab for First-Line Metastatic NSCLC with PD-L1 TPS≥1%
العنوان: | MO01.19 An Indirect Comparison of Pembrolizumab Monotherapy Versus Ipilimumab+Nivolumab for First-Line Metastatic NSCLC with PD-L1 TPS≥1% |
---|---|
المؤلفون: | Halmos, B., Burke, T., Kalyvas, C., Insinga, R., Vandormael, K., Frederickson, A., Piperdi, B. |
المصدر: | In Journal of Thoracic Oncology January 2021 16(1) Supplement:S23-S24 |
قاعدة البيانات: | ScienceDirect |
تدمد: | 15560864 |
---|---|
DOI: | 10.1016/j.jtho.2020.10.067 |